Search and Browse
Download
Enter Data
| Reaction Details | |||
|---|---|---|---|
 | Report a problem with these data | ||
| Target | Mitogen-activated protein kinase 14 | ||
| Ligand | BDBM50375796 | ||
| Substrate/Competitor | n/a | ||
| Meas. Tech. | ChEMBL_474267 (CHEMBL935072) | ||
| IC50 | 0.2±n/a nM | ||
| Citation |  Chen, MH; Fitzgerald, P; Singh, SB; O'Neill, EA; Schwartz, CD; Thompson, CM; O'Keefe, SJ; Zaller, DM; Doherty, JB Synthesis and biological activity of quinolinone and dihydroquinolinone p38 MAP kinase inhibitors. Bioorg Med Chem Lett18:2222-6 (2008) [PubMed] Article | ||
| More Info.: | Get all data from this article, Assay Method | ||
| Mitogen-activated protein kinase 14 | |||
| Name: | Mitogen-activated protein kinase 14 | ||
| Synonyms: | CSAID-binding protein | CSBP | CSBP1 | CSBP2 | CSPB1 | Cytokine suppressive anti-inflammatory drug-binding protein | MAP kinase 14 | MAP kinase MXI2 | MAP kinase p38 alpha | MAPK 14 | MAPK14 | MAX-interacting protein 2 | MK14_HUMAN | MXI2 | Mitogen-activated protein kinase p38 alpha | SAPK2A | Stress-activated protein kinase 2a | p38 MAP kinase alpha/beta | ||
| Type: | Serine/threonine-protein kinase | ||
| Mol. Mass.: | 41286.76 | ||
| Organism: | Homo sapiens (Human) | ||
| Description: | Q16539 | ||
| Residue: | 360 | ||
| Sequence: |
| ||
| BDBM50375796 | |||
| n/a | |||
| Name | BDBM50375796 | ||
| Synonyms: | CHEMBL255403 | ||
| Type | Small organic molecule | ||
| Emp. Form. | C26H22Cl3N3O3 | ||
| Mol. Mass. | 530.83 | ||
| SMILES | C[C@@H](N)C(=O)NCCOc1cc(-c2ccccc2Cl)c2ccc(=O)n(-c3c(Cl)cccc3Cl)c2c1 |wD:1.1,(6.2,-17.24,;6.13,-15.68,;7.35,-14.8,;4.85,-14.8,;3.6,-15.73,;4.81,-13.26,;3.47,-12.52,;2.14,-13.31,;.8,-12.56,;-.53,-13.36,;-.5,-14.9,;-1.82,-15.69,;-1.8,-17.22,;-3.13,-18.01,;-3.11,-19.55,;-1.76,-20.31,;-.44,-19.51,;-.46,-17.97,;.86,-17.18,;-3.16,-14.94,;-4.48,-15.72,;-5.82,-14.98,;-5.84,-13.43,;-7.19,-12.69,;-4.52,-12.64,;-4.54,-11.1,;-5.87,-10.35,;-7.2,-11.14,;-5.9,-8.81,;-4.57,-8.02,;-3.23,-8.77,;-3.2,-10.31,;-1.86,-11.06,;-3.18,-13.4,;-1.86,-12.61,)| | ||
| Structure | 
| ||